Alexia Savignoni

Institut Curie — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

37h-index3.9kcitations188works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(70), Ocular Oncology and Treatments(26), Breast Lesions and Carcinomas(20), Cancer Treatment and Pharmacology(18), Cancer Genomics and Diagnostics(15)

Publications188 total

Abstract PS5-07-16: Cappa, a phase 2 study to evaluate capecitabine plus pembrolizumab as post-operative adjuvant therapy for triple-negative breast cancer with residual disease after neoadjuvant chemo-immunotherapy
Clinical Cancer Research·2026
A prospective trial for breast cancer diagnosis by canine odorology
Nature Communications·2025Open Access
LBA58 PLUME: A single-arm phase II trial of pembrolizumab (pembro) plus lenvatinib (lenva) in patients (pts) with metastatic uveal melanoma (mUM)
Annals of Oncology·2025
2193P Early together: Randomized phase 3 trial of early palliative care (EPC) integration in metastatic uveal melanoma (MUM)
Annals of Oncology·2025
Opioid-free versus opioid-based anaesthesia for free-flap reconstruction surgery of the breast: protocol for a phase III, multicentre, randomised controlled study
BMJ Open·2025Open Access
Randomized trials: When scientific rigor meets field reality
Radiotherapy and Oncology·2024· 4 cited
319TiP NeoBREASTIM: A phase II study of atezolizumab plus RP1 oncolytic immunotherapy in the neoadjuvant setting of triple-negative breast cancer (TNBC)
Annals of Oncology·2024· 1 citedOpen Access
Early palliative care in metastatic uveal melanoma (early together): protocol of a prospective randomized Phase III trial
Melanoma Management·2024Open Access
Management of second ipsilateral breast tumor event: An advocacy for a randomized trial
Cancer/Radiothérapie·2024· 4 cited
Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site
British Journal of Cancer·2023Open Access
Legends to supplementary figures from Chromatin Assembly Factor-1, a Marker of Clinical Value to Distinguish Quiescent from Proliferating Cells
2023Open Access
6 supplementary figures from Chromatin Assembly Factor-1, a Marker of Clinical Value to Distinguish Quiescent from Proliferating Cells
2023Open Access
Data from Chromatin Assembly Factor-1, a Marker of Clinical Value to Distinguish Quiescent from Proliferating Cells
2023Open Access
Legends to supplementary figures from Chromatin Assembly Factor-1, a Marker of Clinical Value to Distinguish Quiescent from Proliferating Cells
2023Open Access
6 supplementary figures from Chromatin Assembly Factor-1, a Marker of Clinical Value to Distinguish Quiescent from Proliferating Cells
2023Open Access
Data from Chromatin Assembly Factor-1, a Marker of Clinical Value to Distinguish Quiescent from Proliferating Cells
2023Open Access
Early together: A randomized phase III study of early palliative care in metastatic uveal melanoma (MUM).
Journal of Clinical Oncology·2022
Helping Patients Communicate With Oncologists When Cancer Treatment Resistance Occurs to Develop, Test, and Implement a Patient Communication Aid: Sequential Collaborative Mixed Methods Study
JMIR Research Protocols·2021· 5 citedOpen Access
Addressing the issue of bias in observational studies: Using instrumental variables and a quasi-randomization trial in an ESME research project
PLoS ONE·2021· 2 citedOpen Access
Selective Ophthalmic Artery Chemotherapy with Melphalan in the Management of Unilateral Retinoblastoma: A Prospective Study
Ophthalmology Retina·2021· 8 cited
page 1 of 10Next →

Frequent Co-authors

Bernard Asselain(14), Xavier Sastre‐Garau(12), Alain Fourquet(10), Jean‐Yves Pierga(10), Laurence Desjardins(9), Marc A. Bollet(8), Brigitte Sigal‐Zafrani(8), Youlia Kirova(8), Hervé J. Brisse(8), Fabien Reyal(8), Isabelle Aerts(7), Nathalie Cassoux(6), Anne Vincent‐Salomon(6), R. Dendale(6), Livia Lumbroso‐Le Rouic(6), François Doz(6), Paul Cottu(6), Geneviève Almouzni(5), Anne de la Rochefordière(5), Rémy Salmon(5)